Agnieszka Wozniak Selected Research

Agnieszka Wozniak Research Topics

Disease

55	Neoplasms (Cancer) 11/2023 - 02/2003
25	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 06/2005
16	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 08/2007
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2016
6	Necrosis 05/2022 - 06/2009
5	Liposarcoma 07/2022 - 01/2011
3	Leiomyosarcoma 07/2022 - 01/2018
3	Disease Progression 05/2022 - 01/2018
3	Cardiotoxicity 04/2022 - 08/2007
2	Ewing Sarcoma (Sarcoma, Ewing) 11/2023 - 06/2008
2	Clear Cell Sarcoma 01/2023 - 12/2021
2	Alopecia (Baldness) 01/2021 - 08/2007
2	Fatigue 01/2021 - 01/2020
2	Synovial Sarcoma (Synovioma) 01/2019 - 01/2017
2	Residual Neoplasm 08/2013 - 01/2011
1	Rhabdomyosarcoma 11/2023
1	Alveolar Soft Part Sarcoma 05/2022
1	Nausea 01/2021
1	Vomiting 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Stomatitis 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 10/2018
1	Fever (Fevers) 01/2018
1	Myocardial Infarction 01/2018
1	Alveolar Rhabdomyosarcoma 01/2018
1	Sepsis (Septicemia) 01/2018
1	Abdominal Abscess 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Systemic Mastocytosis 11/2017

Drug/Important Bio-Agent (IBA)

19	Imatinib Mesylate (Gleevec)FDA Link 04/2023 - 11/2007
12	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022 - 06/2008
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2020 - 06/2005
7	Phosphotransferases (Kinase)IBA 01/2023 - 03/2006
7	CrizotinibIBA 05/2022 - 12/2017
6	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2019 - 04/2008
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2021
4	Anaplastic Lymphoma KinaseIBA 12/2021 - 01/2018
4	Sunitinib (Sutent)FDA Link 01/2020 - 10/2010
3	Cytotoxins (Cytolysins)IBA 11/2023 - 08/2007
3	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2014
3	Ifosfamide FDA LinkGeneric 01/2021 - 06/2008
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2012
3	pazopanib FDA Link 01/2018 - 01/2014
3	TrabectedinIBA 01/2014 - 08/2007
3	tanespimycin (17AAG)IBA 10/2011 - 09/2008
2	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 07/2022
2	plocabulinIBA 07/2022 - 11/2020
2	Tubulin ModulatorsIBA 07/2022 - 11/2020
2	EnzymesIBA 04/2022 - 01/2017
2	ProdrugsIBA 04/2022 - 01/2017
2	eribulin FDA Link 01/2021 - 01/2017
2	cabozantinibIBA 01/2020 - 12/2016
2	Formaldehyde (Formol)FDA Link 01/2019 - 03/2014
2	avapritinibIBA 01/2019 - 11/2017
2	ParaffinIBA 03/2014 - 02/2003
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2011 - 09/2008
2	ErbB Receptors (EGF Receptor)IBA 03/2011 - 09/2010
2	Dasatinib (BMS 354825)FDA Link 09/2010 - 09/2008
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Carboplatin (JM8)FDA LinkGeneric 11/2023
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2023
1	Topoisomerase I InhibitorsIBA 11/2023
1	AntigensIBA 11/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	purineIBA 04/2023
1	IronIBA 10/2022
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 05/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2022
1	DipeptidesIBA 01/2022
1	fibroblast activation protein alphaIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	nintedanibIBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	UbiquitinIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	IpilimumabIBA 10/2019
1	atezolizumabIBA 10/2019
1	Bevacizumab (Avastin)FDA Link 10/2019
1	NivolumabIBA 10/2019
1	olaratumabIBA 07/2019
1	anagrelide (Agrylin)FDA LinkGeneric 01/2019
1	Verteporfin (Visudyne)FDA Link 01/2019
1	CreatinineIBA 01/2018
1	PhAc-ALGP-doxorubicinIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017

Therapy/Procedure

18	Therapeutics 11/2023 - 11/2007
5	Aftercare (After-Treatment) 01/2020 - 08/2012
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2007
1	Transplantation 07/2022
1	Drug Tapering 01/2020
1	Metastasectomy 10/2018